Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

被引：477

作者：

Law, Mansun ^{[1
]}

Maruyama, Toshiaki ^{[1
]}

Lewis, Jamie ^{[4
]}

Giang, Erick ^{[1
]}

Tarr, Alexander W. ^{[5
]}

Stamataki, Zania ^{[6
]}

Gastaminza, Pablo ^{[3
]}

Chisari, Francis V. ^{[3
]}

Jones, Ian M. ^{[7
]}

Fox, Robert I. ^{[8
]}

Ball, Jonathan K. ^{[5
]}

McKeating, Jane A. ^{[6
]}

Kneteman, Norman M. ^{[4
]}

Burton, Dennis R. ^{[1
,2
]}

机构：

[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA

[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA

[3] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA

[4] Univ Alberta, Dept Surg, Edmonton, AB T6G 2S2, Canada

[5] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England

[6] Univ Birmingham, Sch Med, Inst Biomed Res, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England

[7] Univ Reading, Sch Biol Sci, Reading RG6 6AH, Berks, England

[8] Scripps Mem Hosp, Rheumatol Clin, La Jolla, CA 92037 USA

来源：

NATURE MEDICINE | 2008年 / 14卷 / 01期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/nm1698

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A major problem in hepatitis C virus (HCV) immunotherapy or vaccine design is the extreme variability of the virus. We identified human monoclonal antibodies (mAbs) that neutralize genetically diverse HCV isolates and protect against heterologous HCV quasispecies challenge in a human liver-chimeric mouse model. The results provide evidence that broadly neutralizing antibodies to HCV protect against heterologous viral infection and suggest that a prophylactic vaccine against HCV may be achievable.

引用

页码：25 / 27

页数：3

共 15 条

[1] Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].

Bartosch, B ;

Dubuisson, J ;

Cosset, FL .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642

[2] CD81-dependent binding of hepatitis C virus E1E2 heterodimers [J].

Cocquerel, L ;

Kuo, CC ;

Dubuisson, J ;

Levy, S .

JOURNAL OF VIROLOGY, 2003, 77 (19) :10677-10683

[3] Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees [J].

Elmowalid, Gamal A. ;

Qiao, Ming ;

Jeong, Sook-Hyang ;

Borg, Brian B. ;

Baumert, Thomas F. ;

Sapp, Ronda K. ;

Hu, Zongyi ;

Murthy, Krishna ;

Liang, T. Jake .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (20) :8427-8432

[4] A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees [J].

Folgori, A ;

Capone, S ;

Ruggeri, L ;

Meola, A ;

Sporeno, E ;

Ercole, BB ;

Pezzanera, M ;

Tafi, R ;

Arcuri, M ;

Fattori, E ;

Lahm, A ;

Luzzago, A ;

Vitelli, A ;

Colloca, S ;

Cortese, R ;

Nicosia, A .

NATURE MEDICINE, 2006, 12 (02) :190-197

[5] Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles [J].

Hsu, M ;

Zhang, J ;

Flint, M ;

Logvinoff, C ;

Cheng-Mayer, C ;

Rice, CM ;

McKeating, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :7271-7276

[6] Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions [J].

Keck, ZY ;

Op de Beeck, A ;

Hadlock, KG ;

Xia, JM ;

Li, TK ;

Dubuisson, J ;

Foung, SKH .

JOURNAL OF VIROLOGY, 2004, 78 (17) :9224-9232

[7] Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application [J].

Kneteman, Norman M. ;

Weiner, Amy J. ;

O'Connell, John ;

Collett, Marc ;

Gao, Tiejun ;

Aukerman, Lea ;

Kovelsky, Rosemary ;

Ni, Zhi-Jie ;

Hashash, Ahmad ;

Kline, Janine ;

Hsi, Belinda ;

Schiller, Daniel ;

Douglas, Donna ;

Tyrrell, D. Lorne J. ;

Mercer, David F. .

HEPATOLOGY, 2006, 43 (06) :1346-1353

[8] Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro [J].

Lindenbach, BD ;

Meuleman, P ;

Ploss, A ;

Vanwolleghem, T ;

Syder, AJ ;

McKeating, JA ;

Lanford, RE ;

Feinstone, SM ;

Major, ME ;

Leroux-Roels, G ;

Rice, CM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (10) :3805-3809

[9] Characterization of truncated forms of hepatitis C virus glycoproteins [J].

Michalak, JP ;

Wychowski, C ;

Choukhi, A ;

Meunier, JC ;

Ung, S ;

Rice, CM ;

Dubuisson, J .

JOURNAL OF GENERAL VIROLOGY, 1997, 78 :2299-2306

[10] Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding [J].

Owsianka, Ania M. ;

Timms, Judith M. ;

Tarr, Alexander W. ;

Brown, Richard J. P. ;

Hickling, Timothy P. ;

Szwejk, Aleksandra ;

Bienkowska-Szewczyk, Krystyna ;

Thomson, Brian J. ;

Patel, Arvind H. ;

Ball, Jonathan K. .

JOURNAL OF VIROLOGY, 2006, 80 (17) :8695-8704

← 1 2 →